These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14099273)

  • 1. [CONTRIBUTION OF THE THROMBO-TEST IN THE SURVEILLANCE OF ANTICOAGULANT TREATMENTS].
    VERGOZ D; ANDRE R
    Rev Prat; 1963 Dec; 13():SUPPL 141-5. PubMed ID: 14099273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution of thromboelastography and Owren's thrombo-test in the control of long-term anticoagulant treatment].
    RAGER GR
    Gaz Med Fr; 1962 Sep; 69():2379-98. PubMed ID: 13990440
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE CONTROL OF ANTICOAGULANT THERAPY IN MYOCARDIAL INFARCT. THROMBOELASTOGRAPHY AND QUICK'S TIME: CONSIDERATIONS AND COMPARISONS].
    BARBANO G; SOLERA L
    Minerva Med; 1964 Feb; 55():612-8. PubMed ID: 14161162
    [No Abstract]   [Full Text] [Related]  

  • 4. [The biological control of prolonged anticoagulant treatment by thromboelastography].
    DURAFFOURD P
    Acta Clin Belg; 1960; 15():115-26. PubMed ID: 13725149
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thromboelastography as a method of control of anticoagulant treatment in gynecology].
    FERABOLI M
    Pathologica; 1954; 46(723-724):337-46. PubMed ID: 13273089
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE SUPERVISION OF ANTICOAGULANT THERAPY].
    REMDE W
    Z Arztl Fortbild (Jena); 1963 Nov; 57():1246-9. PubMed ID: 14116148
    [No Abstract]   [Full Text] [Related]  

  • 8. [PROTAMINE AND POLYBRENE. ITS ANTICOAGULANT AND ANTIHEPARINIC ACTION].
    SANSALVADOR B; IRIARTEEZCURDIA JA; MONASTERIO J
    Rev Clin Esp; 1964 Jan; 92():112-7. PubMed ID: 14111192
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of thromboelastography (thrombodynamography) in the control of treatments of myocardial infarct with anticoagulants].
    MARCHAL G; LEROUX ME; SAMAMA M
    Pathol Biol; 1960 May; 8():953-8. PubMed ID: 14420877
    [No Abstract]   [Full Text] [Related]  

  • 10. [COMPARATIVE EVALUATION OF THROMBOELASTOGRAPHIC DATA AND SOME BIOCHEMICAL INDICES IN MYOCARDIAL INFARCT AND STENOCARDIA PATIENTS DURING ANTICOAGULANT THERAPY].
    ROMASHOV VP
    Ter Arkh; 1964 Jun; 36():11-7. PubMed ID: 14226949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of a case of hemorrhagic diathesis caused by circulating anticoagulant. Importance of thromboelastography for the diagnosis].
    ROUSSEL-LE GUEN JC; DURAFFOURD P
    Rev Fr Gynecol Obstet; 1961 Apr; 56():317-29. PubMed ID: 13744012
    [No Abstract]   [Full Text] [Related]  

  • 12. [CLINICO-EXPERIMENTAL STUDIES ON THE ANTICOAGULANT WARFARIN-SODIUM].
    LUKOMSKII PE; LAKIN KM; KAZMINA PV
    Kardiologiia; 1965; 5():24-9. PubMed ID: 14259529
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin.
    Simons R; Mallett SV
    Anaesthesia; 2007 Nov; 62(11):1175-8. PubMed ID: 17924901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THROMBOELASTOGRAPHY--ITS POSSIBILITIES IN GERIATRICS].
    JOSELEVICH M; PAPESCHI AJ; FORTE E; PARDAL EM
    Rev Asoc Med Argent; 1963 Sep; 77():446-57. PubMed ID: 14092196
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.
    Bliden KP; Chaudhary R; Mohammed N; Muresan AA; Lopez-Espina CG; Cohen E; Raviv G; Doubleday M; Zaman F; Mathew B; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2017 May; 43(4):437-445. PubMed ID: 28247290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant therapy with rotatory and tolerance thrombelastography].
    MALAGAMBA PD; DE CECCO L
    Zentralbl Gynakol; 1961 Dec; 83():1952-4. PubMed ID: 14468776
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various aspects of thrombelastography control of anticoagulant treatment].
    Aznar J; Tormo V; Herburger E
    Rev Clin Esp; 1968 Jan; 108(1):22-36. PubMed ID: 5740863
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(8):1256-8. PubMed ID: 7192139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.